Using mechanistic physiologically-based pharmacokinetic models to assess prenatal drug exposure: Thalidomide versus efavirenz as case studies
2019 ◽
Vol 140
◽
pp. 105068
◽
2019 ◽
Vol 107
(5)
◽
pp. 1082-1115
◽
2012 ◽
Vol 9
(5)
◽
pp. 1971-1983
◽
2012 ◽
Vol 93
(2)
◽
pp. 152-152
◽
2018 ◽
Vol 58
(2)
◽
pp. 235-262
◽
2020 ◽
pp. 301-321